The blood
Santa Barbara-based BioIQ has signed a deal with UnitedHealthcare to provide the South Coast firm’s at-home health screening kits to as many as 11 million UHC customers.
BioIQ’s packets require a pin prick and a few drops of blood to test for conditions such as diabetes, cancer, heart disease and kidney disease. But what drives BioIQ is a Netflix-like approach to delivering the tests, an easy-to-use Web interface and some heavy-duty backend engineering to make the resulting data compatible with the burgeoning electronic medical records movement.
“We’re trying to re-engineer health care,” said Justin Bellante, BioIQ’s CEO.
The full version of this article is only available in the print edition. To view everything the Business Times offers, see this week’s print version or SUBSCRIBE to the print edition for $49.99 today.
